DYADIC INTERNATIONAL INC

corporate_fare Company Profile

DYADIC INTERNATIONAL INC

Exchange: NASDAQSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed DYAI - Latest Insights

Filing Type

Date Range

DYAI

Mar 27, 2026, 9:56 PM EDT

Filing Type: 8-K

Importance Score:

9

Dyadic International Receives Second Nasdaq Delisting Notice, Citing Financial Metrics Deficiency

Sentiment: Negative

View Wiseek Article

DYAI

Mar 25, 2026, 4:14 PM EDT

Filing Type: 8-K

Importance Score:

7

Dyadic Reports Increased Annual Loss Amidst Significant Commercialization Progress and New Partnerships

Sentiment: Neutral

View Wiseek Article

DYAI

Mar 25, 2026, 4:13 PM EDT

Filing Type: 10-K

Importance Score:

8

Dyadic International Reports Increased Net Loss, Nasdaq Delisting Notice, and Ongoing ATM Program

Sentiment: Negative

View Wiseek Article

DYAI

Mar 16, 2026, 7:20 AM EDT

Source: GlobeNewswire

Importance Score:

8

Dyadic Secures Commercial Distribution Partnership with IBT Bioservices for Recombinant Proteins

Sentiment: Positive

View Wiseek Article

DYAI

Mar 06, 2026, 5:02 PM EST

Filing Type: 424B5

Importance Score:

8

Dyadic International Launches $4.24M At-The-Market Offering, Signaling Significant Dilution

Sentiment: Negative

View Wiseek Article

DYAI

Mar 02, 2026, 7:20 AM EST

Source: GlobeNewswire

Importance Score:

7

Dyadic's Non-Animal Dairy Enzyme Achieves Milestone, Targets 2026 Commercialization

Sentiment: Positive

View Wiseek Article